EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association Between HPV Vaccination and Cervical Dysplasia Severity in HPV-Positive Women

Ali Deniz Erkmen iD, Kevser Arkan iD

Diagnostics · 25.03.2026 · 16 (7) · 979

DOI: 10.3390/diagnostics16070979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 25.03.2026. Verfasst von Ali Deniz Erkmen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Gazi Yaşargil Training and Research Hospital, 21010 Diyarbakır, Turkey. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although HPV vaccination is highly effective in the primary prevention of cervical cancer, its potential role in women already diagnosed with HPV-associated cervical dysplasia remains uncertain. This study aimed to evaluate the association between post-diagnosis HPV vaccination and short-term clinical outcomes in HPV-positive women with cervical dysplasia.

Methods

Women aged ≥18 years with abnormal cervical screening results suggestive of squamous intraepithelial lesions and high-risk HPV positivity were retrospectively evaluated. High-grade disease was defined as histologically confirmed CIN2/3. HPV vaccination (9-valent) was recommended to all eligible patients at the time of diagnosis. Vaccination status was primarily analyzed as vaccinated (≥1 dose) versus unvaccinated; additionally, dose-stratified analyses (0, 1–2, and 3 doses) were performed to explore potential dose–response relationships.

Results

A total of 392 women were included (173 unvaccinated and 219 vaccinated). At 12 months, regression occurred in 51.1% of vaccinated patients compared with 41.0% of unvaccinated women (OR 1.50, 95% CI 1.02–2.20, p = 0.04). A dose–response pattern was observed, with regression rates of 41.0% in unvaccinated patients, 46.1% in partially vaccinated patients, and 54.6% in fully vaccinated patients (p for trend = 0.012). In the HSIL subgroup, regression occurred in 49.0% of vaccinated women versus 33.8% of unvaccinated patients (OR 1.88, 95% CI 1.01–3.52, p = 0.047). When stratified by treatment modality, vaccination was significantly associated with higher regression in the non-LEEP cohort (OR 1.67, p = 0.04) but not in the LEEP cohort (p = 0.22). In multivariable analysis adjusting for age, smoking, HPV genotype, baseline histopathologic grade (CIN1 vs. CIN2/3), and treatment modality, HPV vaccination remained independently associated with regression (aOR 1.55, 95% CI 1.05–2.30, p = 0.028).

Conclusions

Post-diagnosis HPV vaccination was associated with a higher probability of cervical dysplasia regression at 12 months, particularly among women with baseline HSIL. These findings suggest that HPV vaccination may provide a beneficial adjunct effect in the clinical management of HPV-associated cervical dysplasia. Prospective studies are required to confirm these observations and clarify the mechanisms underlying this association.

Schlagwörter

Stichwörter der Autor:innen

CIN2+HPV vaccinationHSILLEEPadjuvant vaccinationcervical dysplasiacervical intraepithelial neoplasiahigh-risk HPVregressionsecondary prevention

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Gazi Yaşargil Training and Research Hospital, 21010 Diyarbakır, Turkey.

ORCID-Profile: Ali Deniz Erkmen, Kevser Arkan

Zitieren

APA

Erkmen, A. D., & Arkan, K. (2026). Association Between HPV Vaccination and Cervical Dysplasia Severity in HPV-Positive Women. Diagnostics, 16(7), 979. https://doi.org/10.3390/diagnostics16070979

Vancouver

Erkmen AD, Arkan K. Association Between HPV Vaccination and Cervical Dysplasia Severity in HPV-Positive Women. Diagnostics. 2026;16(7):979. doi:10.3390/diagnostics16070979

BibTeX
@article{Erkmen2026,
  author = {Erkmen, Ali Deniz and Arkan, Kevser},
  title = {Association Between HPV Vaccination and Cervical Dysplasia Severity in HPV-Positive Women},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {7},
  pages = {979},
  doi = {10.3390/diagnostics16070979}
}
Kostenlos starten →